These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? Drangsholt S, Ruiz MJA, Peyronnet B, Rosenblum N, Nitti V, Brucker B. World J Urol; 2019 Jul; 37(7):1389-1394. PubMed ID: 30288596 [Abstract] [Full Text] [Related]
31. Long-term safety of desmopressin orally disintegrating tablets in men with nocturia due to nocturnal polyuria: Interim results of a specified drug use-results survey in Japan. Ogawa Y, Murata S, Kuramoto K, Nakano A. Low Urin Tract Symptoms; 2024 May; 16(3):e12513. PubMed ID: 38616722 [Abstract] [Full Text] [Related]
32. Pitfalls and opportunities in multidisciplinary research about nocturia in adults. Denys MA, Bruneel E, Van Laecke S, Nørgaard JP, Everaert K. Acta Clin Belg; 2017 Feb; 72(1):2-5. PubMed ID: 27164325 [Abstract] [Full Text] [Related]
34. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Koseoglu H, Aslan G, Ozdemir I, Esen A. Urology; 2006 Jun; 67(6):1188-92. PubMed ID: 16750254 [Abstract] [Full Text] [Related]
36. Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg. Kurose H, Komiya K, Ogasawara N, Ueda K, Chikui K, Nishihara K, Nakiri M, Matsuo M, Suekane S, Igawa T. Low Urin Tract Symptoms; 2023 May; 15(3):89-95. PubMed ID: 36755502 [Abstract] [Full Text] [Related]